|
3.1.1 Prévention - Tabac - e-cigs
|
|
|
|
3.7 Prévention - Alcool
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
FDA Announces Third-Party Review Pathway for Tumor Profiling Tests [RAPS]
|
|
|
|
|
|
FDA
says the IMPACT test is "highly accurate" and can identify mutations in
more genes than any other test it has reviewed in the past. However,
FDA says that while the results of the test can provide valuable
insights to patients and physicians, its results alone "are not
conclusive for choosing a corresponding treatment."
|
|
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.7 Immunothérapies - vaccins
|
|
|
This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person [Bloomberg]
|
|
|
|
|
|
Six
weeks ago, a 1-millimeter cube of cancer tissue collected by doctors
from the right lung of 67-year-old retiree Glenda Cleaver was packed in a
box at the Sarah Cannon Research Institute in Nashville, Tennessee. It
was the beginning of a journey Moderna hopes will lead to a long-sought
goal: a vaccine that trains the body to attack tumors.
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
6.11 Patients
|
|
|
|
6.12 Ethique
|
|
|
Bioethics: Justice in genomics [Nature]
|
|
|
|
|
|
Reardon's
underlying message is one of disappointment. She believes that genomics
has enormous beneficial potential, but sees the human genome as a
currency that so far has been deprived of value because, she alleges, of
a lack of medical breakthroughs resulting from it. This is the major
shortcoming of the book.
|
|
|
|
|
|
|
6.6 Publications
|
|
|
Is There a Business Case for Open Data? [The Scholarly Kitchen]
|
|
|
|
|
|
The
document contains a number of thoughtful pieces from the European
Commission, the Wellcome Trust, and Springer Nature (among others), as
well as the results of Figshare’s second annual survey of researchers
about their experiences with data sharing.
|
|
|
|
|
|
|
6.9 Controverses
|
|
|
Placebo Myths Debunked [Science-Based Medicine]
|
|
|
|
|
|
Desperate
to salvage a role for their preferred but ineffective treatments, many
alternative practitioners will argue that their real expertise is in
maximizing placebo effects. OK, sure, the scientific evidence shows that
my treatment is no better than placebo, but placebo effects are real,
and I am very good at eliciting them. This is the “placebo medicine”
gambit.
|
|
|
|
|
|
|